Abstract:Background Alzheimer's disease (AD) is a common degenerative brain disorder with limited therapeutic options. Curcumin (Cur) exhibits neuroprotective function in many diseases. We aimed to explore the role and mechanism of Cur in AD. Materials and methods Firstly, we established AD mice by injecting amyloid-β1-42 (Aβ1–42) solution into the hippocampus. Then, the AD mice received 150 mg/kg/d Cur for 10 consecutive days. The Morris water maze test was conducted to evaluate the cognitive function of the mice by hidden platform training and probe trials. To assess the spatial memory of the mice, spontaneous alternation behavior, the number of crossing the novel arm and the time spent in the novel arm during the Y-maze test was recorded. Hematoxylin and eosin (H&E) staining and terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNAL) assay were performed to assess the pathological damage and apoptosis of brain tissues. The number of damaged neurons was inspected by Nissl staining. Immunohistochemical staining was then performed to detect Aβ1-42 deposition. The levels of tumor necrosis factor-α (TNF-a), interleukin-6 (IL-6) and interleukin-1β (IL-1β) in serum and hippocampus, the contents of super oxide dismutase (SOD) and malondialdehyde (MDA) in brain tissues were assessed by enzyme-linked immunosorbent assay (ELISA). Additionally, B-cell lymphoma-2 (Bcl-2), Bcl-2 associated X protein (Bax), RelA (p65) protein expressions and Adenosine 5'-monophosphate-activated protein kinase (AMPK) phosphorylation were tested using Western blot. Results Cur not only improved cognitive function and spatial memory, but also alleviated the pathological damage and apoptosis of brain tissues for AD mice. Meanwhile, upon Cur treatment, the number of damaged neurons in AD mice was decreased, the level of Aβ1-42 in AD mice was significantly decreased. Furthermore, the AD mice treated with Cur exhibited lower TNF-a, IL-6, IL-1β and MDA levels and a higher SOD content. Besides, Cur also downregulated p65 expression and upregulated AMPK phosphorylation. Conclusion Cur may improve AD via suppressing the inflammatory response, oxidative stress and activating the AMPK pathway, suggesting that Cur may be a potential drug for AD.

A Curcumin Analog Reduces Levels of the Alzheimer’s Disease-Associated Amyloid-β Protein by Modulating AβPP Processing and Autophagy

A Curcumin Analog Exhibits Multiple Biologic Effects on the Pathogenesis of Alzheimer’s Disease and Improves Behavior, Inflammation, and β-Amyloid Accumulation in a Mouse Model

Curcumin alleviates Alzheimer's disease by inhibiting inflammatory response, oxidative stress and activating the AMPK pathway

Curcumin Mitigates Aβ33-42 Fibril-Induced Neuronal Injury in the Hippocampus

Optimized turmeric extracts have potent anti-amyloidogenic effects

Design, Synthesis, and Biological Evaluation of Curcumin Analogues As Multifunctional Agents for the Treatment of Alzheimer’s Disease

Potential therapeutic effects of curcumin: relationship to microtubule-associated proteins 2 in Aβ1-42 insult.

Study on the Application of a Novel Nano-Curcumin Drug for Alzheimer's Disease

Curcumin Complex Analogues as Near-Infrared Fluorescent Probes for Monitoring all A beta Species in the Early Alzheimer's Disease Model

Curcumin Reduces Hippocampal Neuron Apoptosis and JNK-3 Phosphorylation in Rats with A&beta;-induced Alzheimer&#39;s Disease: Protecting Spatial Learning and Memory

Ppar Gamma Agonist Curcumin Reduces the Amyloid-Beta-Stimulated Inflammatory Responses in Primary Astrocytes

Curcumin Exerts Effects on the Pathophysiology of Alzheimer's Disease by Regulating PI(3,5)P2 and Transient Receptor Potential Mucolipin-1 Expression.

Innate immunity and transcription of MGAT-III and Toll-like receptors in Alzheimer's disease patients are improved by bisdemethoxycurcumin

Curcumin Mediates Presenilin-1 Activity to Reduce Β-Amyloid Production in a Model of Alzheimer’s Disease

The Potential Protective Effect of Curcumin on Amyloid- β -42 Induced Cytotoxicity in HT-22 Cells.

Syntheses and Evaluation of Asymmetric Curcumin Analogues As Potential Multifunctional Agents for the Treatment of Alzheimer’s Disease

Curcumin Derivative GT863 Inhibits Amyloid-Beta Production via Inhibition of Protein N-Glycosylation

The Regulation of Natural Food Dyes Curcumin on the Amyloidogenic Pathway of App

The Inhibitory Effects of Different Curcuminoids on Β-Amyloid Protein, Β-Amyloid Precursor Protein and Β-Site Amyloid Precursor Protein Cleaving Enzyme 1 in Swapp HEK293 Cells.

Antioxidant, anti‐inflammatory and epigenetic potential of curcumin in Alzheimer's disease

Curcumin inhibits BACE1 expression through the interaction between ER and NFB signaling pathway in SH-SY5Y cells